Gatipotuzumab, CAS 1264737-26-9

Product Description: Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Macchini M, et al. Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 gatipotuzumab (GAT) with the anti-EGFR tomuzotuximab (TO) or panitumumab in patients with refractory solid tumors. European Journal of Cancer, 2020, 138: S5-S6./[2]Danielczyk A, et al. PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol Immunother. 2006 Nov;55(11):1337-47.

CAS Number: 1264737-26-9

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: H2O

Target: Mucin

• Artikelnummer: MEXHY-P99634-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99634-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK